QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
Meng Li(Tianjin Medical University Cancer Institute and Hospital), Zhuyuan Fang(Nanjing University of Chinese Medicine)
Cited by 27
Related Papers
Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
|British Journal of Cancer|2017|77